Several presentations at ESMO2023 highlighted significant advancements in the...
LIBRETTO-531, a phase 3 trial, was designed to establish the optimal first-line...
Dr Rachel Galot, medical oncologist at Cliniques Universitaires Saint-Luc in...
In the ADJORL1 study, the efficacy and safety of nivolumab were investigated as...
The research of Dr Natasha Honoré, medical oncologist at UC Louvain, Brussels...
The GORTEC 2014-04 trial sought to assess the efficacy of omitting chemotherapy...
With their combined knowledge and experience, Prof. Paul Clement and Prof....